Escherichia coli OMVs decorated with human epidermal growth factor receptor 2 (HER2) specific antibodies and loaded with siRNAs were shown to target HER2-tumor cells and exert cytotoxic effects (Gujrati et al., 2014). The gene discussed is ERBB2; the disease is neoplasm.